Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-25

Clinical Trial Update: Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts

View source ↗

Summary

This is a registry update for NeVa VS evaluating management of cerebral vasospasm in post-subarachnoid hemorrhage patients; the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NeVa VS

Snippet

Sponsor: Vesalio | Conditions: Cerebral Vasospasm, Aneurysmal Subarachnoid Hemorrhage (aSAH) | Status: NOT_YET_RECRUITING